Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Atherosclerosis and autoimmunity [[electronic resource] /] / editors, Yehuda Shoenfeld, Dror Harats, George Wick
| Atherosclerosis and autoimmunity [[electronic resource] /] / editors, Yehuda Shoenfeld, Dror Harats, George Wick |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier, 2001 |
| Descrizione fisica | 1 online resource (395 p.) |
| Disciplina | 616.1/36079 |
| Altri autori (Persone) |
ShoenfeldYehuda
HaratsDror WickG (Georg) |
| Soggetto topico |
Atherosclerosis - Immunological aspects
Autoimmunity Atherosclerosis - Pathogenesis |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-05970-6
9786611059705 0-08-052765-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Atherosclerosis and Autoimmunity; Copyright Page; Contents; Preface; List of Contributors; Introduction: Autoimmunity as an Additional 'Risk Factor' for Artherosclerosis; Part I: Autoimmunity and Atherosclerosis; Chapter 1. The Autoimmune Pathogenesis of Atherosclerosis - an Evolutionary-Darwinian Concept; Chapter 2. Autoimmune Aspects of Atherosclerosis; Part II: Pathogenetic Immune Mechanism of Atherosclerosis; Chapter 3. The Role of Macrophage Scavenger Receptors in Atherogenesis
Chapter 4. CD36, the Macrophage Class B Scavenger Receptor: Regulation and Role in AtherosclerosisChapter 5. Atherosclerosis, Matrix-Metalloproteinases (MMPs) and Ischemia/Hypoxia; Chapter 6. Ceramide Pathway and Apoptosis in Autoimmunity and Atherosclerosis; Chapter 7. a a-Defensins: Potential Link between Inflammation, Thrombosis and Atherosclerosis; Chapter 8. Lipids and Immunity; Part III: Infections, Immunity and Atherosclerosis; Chapter 9. Immune Activation Augments Infection-Dependent Atherogenesis Chapter 10. Host Response Differences to Infection May Affect Disease Susceptibility in Atherosclerotic PatientsChapter 11. The Role of Chronic Infection in Atherosclerosis; Part IV: Atherosclerosis Related Autoantibodies; Chapter 12. Atherosclerosis: Evidence for the Role of Autoimmunity; Chapter 13. Oxidized Autoantigens in Atherosclerosis; Chapter 14. Autoantibodies against Oxidized Palmitoyl Arachidonoyl Phosphocholine in Atherosclerosis; Chapter 15. Autoantibodies to Endothelial Cells and Oxidized LDL in Human Atherosclerosis and Hypertension Chapter 16. Technical and Clinical Aspects about Autoantibody Assays for Oxidized Low Density LipoproteinChapter 17. Is There a Role for Paraoxonase in Atherosclerosis and in Antiphospholipid Syndrome?; Chapter 18. Anti-Prothrombin Antibodies in Thrombosis and Atherosclerosis; Chapter 19. Detection of Cellular Activity in Atherosclerosis by the Novel Cellscan System; Part V: Anti-Endothelial Cell Antibodies (AECA) and Atherosclerosis Section Editors: Pierre Youinou and Pier-Luigi Meroni; Chapter 20. Pathogenicity of Antiendothelial Cell Autoantibodies Chapter 21. Functional Heterogeneity of Pathogenic Anti-Endothelial Cell AntibodiesChapter 22. The Aspect of Anti-Proteinase 3 Antibodies as AECA; Chapter 23. Anti-Endothelial Cell Antibodies (AECA) in Systemic Lupus Erythematosus: Clinical Relevance; Chapter 24. Endothelial Cell Dysfunction in Atherosclerosis and Autoimmunity; Chapter 25. Modulation of Endothelial Cell Function by Normal Poly specific Human Immunoglobulins (IVIg); Part VI: Accelerated Atherosclerosis in Disease; Chapter 26. Cardiovascular Morbidity in the Hopkins Lupus Cohort Chapter 27. Atherosclerosis in Systemic Lupus Erythematosus: Clinical Relevance |
| Record Nr. | UNINA-9910449834903321 |
| Amsterdam ; ; New York, : Elsevier, 2001 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atherosclerosis and autoimmunity / / editors, Yehuda Shoenfeld, Dror Harats, George Wick
| Atherosclerosis and autoimmunity / / editors, Yehuda Shoenfeld, Dror Harats, George Wick |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier, 2001 |
| Descrizione fisica | 1 online resource (395 p.) |
| Disciplina | 616.1/36079 |
| Altri autori (Persone) |
ShoenfeldYehuda
HaratsDror WickG (Georg) |
| Soggetto topico |
Atherosclerosis - Immunological aspects
Autoimmunity Atherosclerosis - Pathogenesis |
| ISBN |
1-281-05970-6
9786611059705 0-08-052765-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Atherosclerosis and Autoimmunity; Copyright Page; Contents; Preface; List of Contributors; Introduction: Autoimmunity as an Additional 'Risk Factor' for Artherosclerosis; Part I: Autoimmunity and Atherosclerosis; Chapter 1. The Autoimmune Pathogenesis of Atherosclerosis - an Evolutionary-Darwinian Concept; Chapter 2. Autoimmune Aspects of Atherosclerosis; Part II: Pathogenetic Immune Mechanism of Atherosclerosis; Chapter 3. The Role of Macrophage Scavenger Receptors in Atherogenesis
Chapter 4. CD36, the Macrophage Class B Scavenger Receptor: Regulation and Role in AtherosclerosisChapter 5. Atherosclerosis, Matrix-Metalloproteinases (MMPs) and Ischemia/Hypoxia; Chapter 6. Ceramide Pathway and Apoptosis in Autoimmunity and Atherosclerosis; Chapter 7. a a-Defensins: Potential Link between Inflammation, Thrombosis and Atherosclerosis; Chapter 8. Lipids and Immunity; Part III: Infections, Immunity and Atherosclerosis; Chapter 9. Immune Activation Augments Infection-Dependent Atherogenesis Chapter 10. Host Response Differences to Infection May Affect Disease Susceptibility in Atherosclerotic PatientsChapter 11. The Role of Chronic Infection in Atherosclerosis; Part IV: Atherosclerosis Related Autoantibodies; Chapter 12. Atherosclerosis: Evidence for the Role of Autoimmunity; Chapter 13. Oxidized Autoantigens in Atherosclerosis; Chapter 14. Autoantibodies against Oxidized Palmitoyl Arachidonoyl Phosphocholine in Atherosclerosis; Chapter 15. Autoantibodies to Endothelial Cells and Oxidized LDL in Human Atherosclerosis and Hypertension Chapter 16. Technical and Clinical Aspects about Autoantibody Assays for Oxidized Low Density LipoproteinChapter 17. Is There a Role for Paraoxonase in Atherosclerosis and in Antiphospholipid Syndrome?; Chapter 18. Anti-Prothrombin Antibodies in Thrombosis and Atherosclerosis; Chapter 19. Detection of Cellular Activity in Atherosclerosis by the Novel Cellscan System; Part V: Anti-Endothelial Cell Antibodies (AECA) and Atherosclerosis Section Editors: Pierre Youinou and Pier-Luigi Meroni; Chapter 20. Pathogenicity of Antiendothelial Cell Autoantibodies Chapter 21. Functional Heterogeneity of Pathogenic Anti-Endothelial Cell AntibodiesChapter 22. The Aspect of Anti-Proteinase 3 Antibodies as AECA; Chapter 23. Anti-Endothelial Cell Antibodies (AECA) in Systemic Lupus Erythematosus: Clinical Relevance; Chapter 24. Endothelial Cell Dysfunction in Atherosclerosis and Autoimmunity; Chapter 25. Modulation of Endothelial Cell Function by Normal Poly specific Human Immunoglobulins (IVIg); Part VI: Accelerated Atherosclerosis in Disease; Chapter 26. Cardiovascular Morbidity in the Hopkins Lupus Cohort Chapter 27. Atherosclerosis in Systemic Lupus Erythematosus: Clinical Relevance |
| Record Nr. | UNINA-9910828103303321 |
| Amsterdam ; ; New York, : Elsevier, 2001 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autoantibodies / / edited by Yehuda Shoenfeld M.D., FRCP, MACR, Professor of Rheumatology, Head, Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni M.D., Professor of Rheumatology Department of Clinical Sciences and Community Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA
| Autoantibodies / / edited by Yehuda Shoenfeld M.D., FRCP, MACR, Professor of Rheumatology, Head, Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni M.D., Professor of Rheumatology Department of Clinical Sciences and Community Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Waltham, MA : , : Elsevier, , 2014 |
| Descrizione fisica | 1 online resource (lx, 855 pages) : illustrations (some color) |
| Disciplina | 616.978 |
| Altri autori (Persone) |
ShoenfeldYehuda
MeroniPier-Luigi GershwinM. Eric <1946-> |
| Collana | Elsevier science & technology books |
| Soggetto topico |
Autoantibodies
Autoimmune diseases - Etiology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-444-59377-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | part 1. Introduction : autoantibodies-unique characteristics -- part 2. Allergic disease autoantibodies -- part 3. Antineutrophil antibodies -- part 4. Introduction : antinuclear antibodies -- part 5. Autoantibodies to biologic factors/structures -- part 6. Cardiac autoantibodies -- part 7. Endocrine autoantibodies -- part 8. GI and liver autoantibodies -- part 9. Hematologic autoantibodies -- part 10. Kidney autoantibodies -- part 11. Neurological system autoantibodies -- part 12. Rheumatic disease autoantibodies -- part 13. Skin disease autoantibodies -- part 14. Unique clinical situations. |
| Record Nr. | UNINA-9910453291703321 |
| Waltham, MA : , : Elsevier, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autoantibodies / / edited by Yehuda Shoenfeld, M.D., FRCP, MACR, Professor of Rheumatology, Head: Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni, M.D., Professor of Rheumatology, Department of Clinical Sciences and Community, Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin, M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA
| Autoantibodies / / edited by Yehuda Shoenfeld, M.D., FRCP, MACR, Professor of Rheumatology, Head: Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni, M.D., Professor of Rheumatology, Department of Clinical Sciences and Community, Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin, M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Waltham, MA : , : Elsevier, , 2014 |
| Descrizione fisica | 1 online resource (lx, 855 pages) : illustrations (some color) |
| Disciplina | 616.978 |
| Collana |
Gale eBooks
Elsevier science & technology books |
| Soggetto topico | Autoantibodies |
| ISBN | 0-444-59377-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | part 1. Introduction : autoantibodies-unique characteristics -- part 2. Allergic disease autoantibodies -- part 3. Antineutrophil antibodies -- part 4. Introduction : antinuclear antibodies -- part 5. Autoantibodies to biologic factors/structures -- part 6. Cardiac autoantibodies -- part 7. Endocrine autoantibodies -- part 8. GI and liver autoantibodies -- part 9. Hematologic autoantibodies -- part 10. Kidney autoantibodies -- part 11. Neurological system autoantibodies -- part 12. Rheumatic disease autoantibodies -- part 13. Skin disease autoantibodies -- part 14. Unique clinical situations. |
| Record Nr. | UNINA-9910790757303321 |
| Waltham, MA : , : Elsevier, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autoantibodies / / edited by Yehuda Shoenfeld, M.D., FRCP, MACR, Professor of Rheumatology, Head: Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni, M.D., Professor of Rheumatology, Department of Clinical Sciences and Community, Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin, M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA
| Autoantibodies / / edited by Yehuda Shoenfeld, M.D., FRCP, MACR, Professor of Rheumatology, Head: Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni, M.D., Professor of Rheumatology, Department of Clinical Sciences and Community, Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin, M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Waltham, MA : , : Elsevier, , 2014 |
| Descrizione fisica | 1 online resource (lx, 855 pages) : illustrations (some color) |
| Disciplina | 616.978 |
| Collana |
Gale eBooks
Elsevier science & technology books |
| Soggetto topico | Autoantibodies |
| ISBN | 0-444-59377-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | part 1. Introduction : autoantibodies-unique characteristics -- part 2. Allergic disease autoantibodies -- part 3. Antineutrophil antibodies -- part 4. Introduction : antinuclear antibodies -- part 5. Autoantibodies to biologic factors/structures -- part 6. Cardiac autoantibodies -- part 7. Endocrine autoantibodies -- part 8. GI and liver autoantibodies -- part 9. Hematologic autoantibodies -- part 10. Kidney autoantibodies -- part 11. Neurological system autoantibodies -- part 12. Rheumatic disease autoantibodies -- part 13. Skin disease autoantibodies -- part 14. Unique clinical situations. |
| Record Nr. | UNINA-9910820711503321 |
| Waltham, MA : , : Elsevier, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autoimmune Disorders : Adjuvants and Other Risk Factors in Pathogenesis
| Autoimmune Disorders : Adjuvants and Other Risk Factors in Pathogenesis |
| Autore | Watad Abdulla |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Newark : , : John Wiley & Sons, Incorporated, , 2024 |
| Descrizione fisica | 1 online resource (369 pages) |
| Altri autori (Persone) |
BragazziNicola Luigi
ShoenfeldYehuda |
| ISBN |
1-119-85842-9
1-119-85843-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Introduction -- References -- 1 Hyperstimulation of the Immune System -- Background -- Biomaterials that are lined to hyperstimulation of the immune system (silicone, mesh and heavy metals) -- Hyperstimulation syndrome induced by silicone breast implants -- Hyperstimulation syndrome induced by mesh -- Hyperstimulation syndrome induced by metals -- Link among foreign bodies, chronic stimulation, and lymphoproliferative disorders -- Studies on silicone, metals, and the risk of lymphoma -- References -- 2 Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA): Genetics, Immunization, and Autoimmunity -- Introduction -- Genetic background -- Immunity -- Autoimmunity -- Conclusion -- References -- 3 Vaccine Adjuvants: History, Role, Mechanisms of Action, and Side Effects -- Introduction -- Materials and methods -- Etymology of adjuvants -- Classification of adjuvants -- Mineral salts -- Emulsions -- Bacterial- or microbial-derived adjuvants -- TLR agonists -- Lipid particles/liposomes -- Microparticles/nanoparticles -- Cytokine- and interleukin-based adjuvants -- Adjuvant delivery systems -- History of adjuvants -- Role and mechanisms of actions of adjuvants -- Safety and side effects -- Safety and side effects of aluminum-adjuvanted vaccines -- Safety and side effects of emulsion-adjuvanted vaccines -- Safety and side effects of novel adjuvants -- Overall synthesis of safety and side effects of adjuvanted vaccines -- Conclusions and future directions -- References -- 4 Commonly Used Food Additives Are Nutritional Adjuvants in ASIA Syndrome -- Introduction -- ASIA syndrome -- Increased usage of food additives in the processed food industries -- Gluten is a nutritional adjuvant -- Gluten side effects -- Gluten-depended autoimmunity.
Gluten fulfills the diagnostic criteria of ASIA syndrome -- Microbial transglutaminase is a potential new adjuvant -- Microbial transglutaminase is a potential inducer of autoimmune disease -- Microbial transglutaminase fulfills the diagnostic criteria of ASIA syndrome -- Nanoparticle complexes are potential new adjuvants -- Nanoparticles fulfill the criteria of ASIA syndrome -- Food colorants are potential new adjuvants -- Food colorants fulfill the criteria of ASIA syndrome -- Emulsifiers are potential new adjuvants -- Emulsifiers fulfill the criteria of ASIA syndrome -- Conclusions -- Abbreviations -- Author contributions -- References -- 5 Silicone Implant Incompatibility Syndrome -- Highlights -- Introduction -- Silicone as an immunologic adjuvant -- Pathophysiological mechanisms of inflammatory/immunological disturbances related to SBI -- Silicone implant incompatibility syndrome -- Autoimmune diseases in patients with SIIS -- Effectivity of SBI explantation in improving symptoms and laboratory findings -- SIIS, who might be at risk? -- Conclusion -- Abbreviations -- References -- 6 Silicone Breast Implants (SBIs) and Autoimmune Dysautonomya -- References -- 7 Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA or Shoenfeld's Syndrome) Due to Polypropylene Mesh Implants -- Introduction -- Adverse events associated with mesh implants -- Systemic symptoms and signs of mesh-mediated systemic disease -- Laboratory and radiological findings and other diagnostic procedures in mesh-induced disease -- ASIA, autoimmune diseases, and lymphoma development -- ASIA: autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) -- Pathophysiology of ASIA after foreign body implantation -- Evidence that mesh can cause ASIA -- Exposure to mesh implants precedes the onset or worsening of symptoms. The appearance of "typical" clinical manifestations -- Removal of inciting agent induces improvement -- Biological plausibility of mesh implants as a cause of ASIA -- Approaches to causation -- Koch's postulates -- Bradford-Hill criteria -- Conclusion -- References -- 8 Vaccines, Vaccinosis, and Autoimmunity -- Vaccines and their epidemiological, clinical, societal, and economic impact -- Vaccines, vaccinosis, and autoimmunity -- Vaccines and immune system activation -- Autoimmune diseases: background and mechanisms -- Vaccine adjuvants: purpose and impact -- Adjuvants and autoimmunity: the body of currently available evidence -- Regulatory measures and ongoing research -- Conclusion -- References -- 9 Sustained Immune Activation in ASIA Syndrome - A Bridge to Lymphomagenesis -- Background -- Introduction -- Animal model as a proof of concept -- Autoimmunity and lymphoma: role of immune chronic stimulation in lymphoma development -- Vaccination and acute lymphoma development -- Foreign body reaction (FBR) and lymphoma -- Silicone versus aluminum compounds and lymphomagenesis association -- Lymphomagenesis in inflammatory diseases from a different perspective -- Conclusions and future goals -- References -- 10 Chronic Fatigue Syndrome -- Introduction -- The evolutionary history of "chronic fatigue syndrome" -- 1750, Febricula -- 1879, Neurocirculatory asthenia -- 1934, Atypical poliomyelitis -- 1948, Akureyri disease (Iceland disease) -- 1955, Royal Free disease -- 1955-1986, Myalgic encephalomyelitis -- 1984, Tapanui outbreak -- 1984, Chronic Epstein-Barr virus syndrome -- 1987, Chronic fatigue syndrome -- CFS syndrome through modern concepts -- Conclusion -- References -- 11 Autoantibodies and Autonomic Nervous System -- G-protein-coupled receptor antibodies: basic facts and historical perspective. Associations between anti-GPCR antibodies and clinical manifestations of dysautonomia -- The autoimmune concept for dysautonomia -- Potential treatment strategy of dysautonomia -- References -- 12 Postural Orthostatic Tachycardia Syndrome (POTS) as a Part of ASIA Syndrome -- Introduction -- POTS and autoantibodies -- POTS and chronic inflammation -- POTS and other autoimmune diseases -- POTS and small-fiber neuropathy (SFN) -- Targeting autoimmunity for POTS treatment -- POTS being one of the many arms of ASIA syndrome -- References -- 13 Role of the Small-fiber Neuropathy in the Pathogenesis of ASIA Syndrome -- Small-fiber neuropathy: definition and principles of diagnostics -- Etiology and pathogenesis -- Clinical manifestations -- Diagnostic methods -- Small-fiber neuropathy treatment -- SFN as part of ASIA syndrome -- Sarcoidosis -- Sjögren's syndrome -- Silicone implant incompatibility syndrome -- Conclusion -- References -- 14 Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants -- Introduction -- Tattoo and its components -- Sjögren's syndrome and tattoo -- Sarcoidosis and tattoo -- Postural orthostatic tachycardia syndrome, ASIA syndrome, and tattoo -- Similarities between silicone incompatibility syndrome (SIS) and ASIA syndrome following tattoo -- Potential therapies for ASIA syndrome following tattoo -- Conclusion -- References -- 15 The Sick Building Syndrome as a Part of the Autoimmune (Autoinflammatory) Syndrome Induced by Adjuvant -- Introduction -- Manifestations of SBS -- Development of SBS: potential hazards and sources -- Conventional and green buildings -- Legal requirements and regulations -- SBS and Autoimmune (Autoinflammatory) Syndrome Induced by Adjuvants (ASIA) -- Conclusion -- References -- 16 Gulf War Syndrome (GWS) and ASIA Syndrome -- Introduction -- Prevalence of GWS. Heterogeneity of Clinical Manifestations -- Etiology and pathogenesis of GWS -- Environmental triggers associated with GWS -- The link between GWS and pesticides -- The link between GWS and nerve agents -- The link between GWS and pyridostigmine bromide (PB) -- The link between GWS and multiple vaccinations -- Genetic basis of individual variation in susceptibility to GWS -- Brain defects and central nervous system alterations in veterans with GWS -- Peripheral immune abnormalities associated with GWS -- Gut microbiome alterations in GWS -- GWS in relation to other multisymptom conditions -- GWS in relation to chronic fatigue syndrome (CFS) -- GWS in relation to fibromyalgia (FM) -- GWS in relation to multiple chemical sensitivity (MCS) -- Classification of GWS as part of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) -- Conclusion -- References -- 17 Vaccinations in Patients with Autoimmune Diseases -- Risk of infection in patients with AIRD -- Safety and efficacy of vaccinations in patients with AIRD -- Influenza vaccines -- Pneumococcal vaccine in AIRD patients -- Hepatitis B vaccine -- Quadrivalent HPV vaccine -- Tetanus and diphtheria vaccines -- References -- 18 Autoimmune Phenomena in Cancer Patients Treated with Immune Checkpoint Inhibitors -- Introduction -- Incidence and autoimmune irAEs -- Inflammatory arthritis -- Sicca syndrome/Sjögren's syndrome -- Myositis and neurological diseases -- Autoimmune diseases -- Vasculitis -- Systemic lupus erythematosus -- Sarcoidosis -- Organ-specific irAEs determined by specific ICI -- Management and treatment of autoimmune irAEs -- Summary -- References -- 19 Heavy Metals in Autoimmune Diseases: Too Much Noise in Autoimmunity -- Chapter highlights -- Introduction -- How metals affect the immune system -- Metals and systemic lupus erythematosus -- Nickel and SLE -- Aluminum and SLE. Cadmium and SLE. |
| Record Nr. | UNINA-9910877497303321 |
Watad Abdulla
|
||
| Newark : , : John Wiley & Sons, Incorporated, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Rheumatic Disease in Geriatrics : Diagnosis and Management / / edited by Gleb Slobodin, Yehuda Shoenfeld
| Rheumatic Disease in Geriatrics : Diagnosis and Management / / edited by Gleb Slobodin, Yehuda Shoenfeld |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (391 pages) |
| Disciplina | 616.723 |
| Soggetto topico | Rheumatology |
| ISBN | 3-030-44234-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Aging and rheumatology -- Prevalence and significance of rheumatic conditions in geriatric population -- Musculoskeletal system in elderly -- Immune system in elderly -- Pharmacokinetics and anti-rheumatic drugs in elderly -- Non Steroidal AntiInflammatory Drugs -- Synthetic Disease Modifying anti-Rheumatic Drugs -- Biological Disease Modifying anti-Rheumatic Drugs -- Glucocorticosteroids -- Opiates and Cannabis -- Comorbidities of rheumatic diseases in geriatric patients -- Cardiovacular -- Pulmonary -- Osteoporosis -- Ophtalmologic -- Vaccination of elderly patients with rheumatic diseases -- Laboratory diagnostics of rheumatic diseases in elderly -- Musculoskeletal imaging in geriatric patients -- Rheumatic disorders in elderly -- Rheumatoid arthritis -- Systemic lupus erythematosus -- Systemic sclerosis, Sjogren’s syndrome and other systemic autoimmune diseases -- Gout -- Calcium pyrophosphate dehydrate deposition disease -- Osteoarthritis -- Giant cell arteritis -- Polymyalgia rheumatic -- Spondyloarthritis -- Septic arthritis -- Autoinflammatory diseases -- Fibromyalgia -- Rheumatic conditions related to malignancies and their treatment -- Approach to a geriatric patient with suspected rheumatic condition -- Approach to a geriatric patient with monoarthritis -- Approach to a geriatric patient with polyarthritis -- Approach to a geriatric patient with shoulder pain -- Approach to a geriatric patient with widespread pain -- Approach to a geriatric patient with intractable back pain -- Approach to a geriatric patient with suspected myopathy -- Approach to a geriatric patient with suspected vasculitis -- Approach to a geriatric patient in pain clinic -- Rehabilitation of an elderly patient with rheumatic disorder. . |
| Record Nr. | UNINA-9910484510903321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||